List of top 200 securities held by Parallel Advisors LLC:
- Institutional investors with $100 million or more in holdings are required to report their portfolio holdings on a quarterly basis within 45 days of the end of a calendar quarter.
- The table below lists top 200 holdings for the reported quarter.
- Portfolio values with missing quarterly reports are assigned zero.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Quarter: 2022Q4
Report Date Time: 2025-04-07 18:10:34
Total Holdings: 19
Assets Under Management (AUM) :
$109,095,053 ($109.095M)
Reporting Manager: Arthur Cohen
Address:
31 HUDSON YARDS, 11TH FLOOR
OFFICE 60
NEW YORK, NY 10001
Since 2013-06-30: total money flow = -$4.049B, gains and losses = $2.504B
| 1 | BIOMARIN PHARMACEUTICAL INC BMRN | 2022Q4 | 367,765 | $38.06M ($103.49) | 34.89% |  | | History |
| 2 | DEXCOM, INC DXCM | 2022Q4 | 321,380 | $36.393M ($113.24) | 33.36% | | | History |
| 3 | CYTOKINETICS INC CYTK | 2022Q4 | 164,440 | $7.535M ($45.82) | 6.91% | | | History |
| 4 | ACRIVON THERAPEUTICS INC ACRV | 2022Q4 | 284,201 | $3.274M ($11.52) | 3.00% | | | History |
| 5 | HYPERFINE INC CORP HYPR | 2022Q4 | 3,880,900 | $3.26M ($0.84) | 2.99% | | | History |
| 6 | ALKERMES PLC ALKS | 2022Q4 | 110,000 | $2.874M ($26.13) | 2.63% | | | History |
| 7 | CONMED CORPORATION CNMD | 2022Q4 | 27,500 | $2.438M ($88.64) | 2.23% | | | History |
| 8 | NEUROCRINE BIOSCIENCES INC NBIX | 2022Q4 | 20,000 | $2.389M ($119.44) | 2.19% | | | History |
| 9 | SYNDAX PHARMACEUTICALS INC SNDX | 2022Q4 | 70,000 | $1.782M ($25.45) | 1.63% | | | History |
| 10 | CHINOOK THERAPEUTICS INC KDNY | 2022Q4 | 60,000 | $1.572M ($26.20) | 1.44% | | | History |
Showing 1 to 10 of 19 entries
×